Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Peringkat dalam Saham #33721
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Harga Saham
$0.4732
Terakhir disinkronkan: 2022-10-26
Kapitalisasi Pasar
$7.05M
Perubahan (1 hari)
-0.03%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan GBS Inc. (GBS)

Kategori

Riwayat harga saham GBS Inc. (GBS)
Harga penutupan tertinggi: $0.49 pada 2022-10-01

Harga penutupan terendah: $9.14 pada 2020-12-01
Riwayat harga saham GBS Inc. dari 2020 hingga 2026
Performa harga saham tahunan
Tahun Performa
2022 -69.81%
2021 -82.27%
2020 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US